BRC Investment Management’s Biogen BIIB Stock Holding History

BRC Investment Management’s Portfolio BIIB Stock Details BIIB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q3	$3.08M	Buy	+9,830	New	+$2.91M	0.52%	87
2015 Q3	–	Sell	-3,203	Closed	-$1.29M	–	119
2015 Q2	$1.29M	Sell	3,203 -49,350	-94%	-$19.8M	0.18%	48
2015 Q1	$22.2M	Sell	52,553 -9,595	-15%	-$3.78M	3.07%	3
2014 Q4	$21.1M	Buy	62,148 +6,772	+12%	+$2.19M	2.86%	10
2014 Q3	$18.3M	Sell	55,376 -1,404	-2%	-$463K	2.79%	13
2014 Q2	$17.9M	Buy	56,780 +2,798	+5%	+$842K	2.58%	17
2014 Q1	$16.5M	Sell	53,982 -156	-0.3%	-$49.5K	2.6%	16
2013 Q4	$15.1M	Buy	+54,138	New	+$14M	2.47%	18

Other funds holding BIIB

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

BRC Investment Management's BIIB Position: Q3 2016 in Review

BRC Investment Management opened a new position in Biogen (BIIB) in Q3 2016: 9,830 shares worth $3.08M. The stake represents 0.52% of the portfolio and ranks #87 among its holdings. This is a return to the name: BRC Investment Management previously reported a position in BIIB as recently as Q2 2015.

BRC Investment Management first reported a position in BIIB in Q4 2013 and has held it in 8 quarters since. The position peaked at $22.2M in Q1 2015. 1,012 funds tracked by Wall St. Rank hold BIIB as of Q3 2016.

BRC Investment Management held 9,830 shares of Biogen worth $3.08M as of Q3 2016.
Biogen was a new BRC Investment Management position in Q3 2016.
Biogen made up 0.52% of BRC Investment Management's portfolio in Q3 2016, its #87 holding.
BRC Investment Management first reported a position in Biogen in Q4 2013 and has held it in 8 quarters since.
BRC Investment Management's Biogen position peaked at $22.2M in Q1 2015.
1,012 funds tracked by Wall St. Rank held Biogen as of Q3 2016.

Based on BRC Investment Management's 13F filing for Q3 2016, filed 31 Oct 2016.